AP
ALKERMES PLC
ALKS· Health Care· PharmaceuticalsS&P 600
Close · 16/09/2026
46.07
1D
+0.09%52-week range
26.5 – 55.67
Volume
18,54,600.00
Price history
ALKS
17/08/2026 to 16/09/2026
O 46.64 H 47.26 L 45.79
1W+1.48%
1M-7.58%
3M+4.49%
6M+66.62%
1Y+73.72%
3Y+56.06%
5Y+53.67%
MAX+92.28%
Fundamentals
as of 16/09/2026- Market cap
- $7.73B
- Shares out
- 167.76M
- P/E (trailing)
- 116.89
- P/E (forward)
- 25.14
- EPS (trailing)
- 0.39
- Beta
- 0.26
- Profit margin
- 3.97%
- P/B
- 4.27
- Return on equity
- 3.66%
SEC financial statements
49 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- ALKS
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 1 buy · 0 sells · D: 1
- 30/07/2026Gilbert CisnerosBuyAlkermes plc - Ordinary Shares$15,001–$50,000